Goldman Removes Hologic From Conviction Buy List, Maintains Buy

By: via Benzinga
Goldman Sachs’ Isaac Ro believes that with the early adoption curve for Hologic, Inc. (NASDAQ: HOLX)'s tomosynthesis ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.